Analytical Data
-
基因名
NR1D2
- Application
-
别名
HZF2; BD73; EAR-1r; RVR; Rev-ErbA Beta; Orphan nuclear hormone receptor BD73; Rev-erb alpha-related receptor; V-erbA-related protein 1-related
-
种属
Rat
-
表达系统
E. coli
-
标签
N- His & GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q63504
-
表达区间
Lys249~Pro578
-
分子量
67kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
NR1D2 (Nuclear Receptor Subfamily 1 Group D Member 2), also known as Rev-Erbβ, is a member of the nuclear receptor superfamily that plays a critical role in various biological processes, including circadian rhythms, metabolism, and immune response. Research on NR1D2 has gained traction due to its pivotal function in regulating gene expression and mediating the effects of hormones and metabolic signals. NR1D2 acts as a transcriptional repressor for several target genes, influencing the expression of proteins involved in lipid metabolism and inflammatory responses. The dysregulation of NR1D2 is implicated in a range of diseases, including obesity, diabetes, and cardiovascular disorders, making it a potential therapeutic target. Furthermore, its role in circadian biology highlights the importance of time-of-day in physiological processes and suggests that manipulating NR1D2 activity could lead to novel chronobiological therapies. Protein engineering and recombinant protein studies of NR1D2 provide insights into its functional mechanisms and interactions, paving the way for better understanding its role in health and disease. Overall, the study of NR1D2 and its recombinant protein forms holds promise for elucidating its complex regulatory networks and developing new strategies for managing metabolic and circadian-related disorders.












